{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,16]],"date-time":"2026-11-16T05:33:32Z","timestamp":1794807212074,"version":"4.9.1"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,5,26]],"date-time":"2025-05-26T00:00:00Z","timestamp":1748217600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,5,26]],"date-time":"2025-05-26T00:00:00Z","timestamp":1748217600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Medizinische Fakult\u00e4t Mannheim der Universit\u00e4t Heidelberg"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Psychiatry"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Schizophrenia is one of the most severe and costly mental disorders in terms of human suffering and societal expenditure. About 15\u201330% of patients do not respond to all known antipsychotics, including clozapine, the current gold standard in these cases. Electroconvulsive therapy (ECT) is well-known to be highly effective in clozapine-treatment-resistant schizophrenia (CRS), and synergistic effects of clozapine and ECT have been demonstrated. However, relapse rates after successful courses of ECT are still very high, and evidence for maintenance ECT (mECT) in CRS is scarce at best.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>Here, we present the protocol of the MECT-RESIST trial, a German multi-center, observer-blind, randomized, and actively controlled parallel-group clinical trial. The scientific aim of the study is to test the hypothesis that mECT plus treatment as usual (TAU) (intervention group) is superior to TAU alone (control group) for relapse prevention in CRS. The primary endpoint is time to relapse. Secondary endpoints include the proportion of relapse-free patients, the global level of functioning and quality of life, depressive symptoms, overall symptoms of schizophrenia, concomitant catatonic symptoms, stress and self-stigmatization and cognitive performance. We aim at randomizing 84 patients between 18 and 65 years with a clinically diagnosed CRS and brief psychotic rating scale (BPRS)\u2009&gt;\u200945, who responded to a series of ECT (BPRS\u2009&lt;\u200970% of initial BPRS), to either recieve mECT\u2009+\u2009TAU or TAU over a period of 28 weeks followed by a follow-up of 12 months. The study will be performed between 2025 and 2028.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Discussion<\/jats:title>\n            <jats:p>In this multi-center trial, we aim to examine the effectiveness of mECT in CRS patients who improved after a course of routine ECT. If mECT will lead to a longer time to relapse and\/or to a higher proportion of relapse-free patients compared to those undergoing treatment as usual, this trial would have an enormous impact on therapeutic strategies for patients with CRS and would induce a profound change of current treatment guidelines, where ECT still ranks at the level of ultima ratio, despite accumulating evidence suggesting otherwise.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Trial registration<\/jats:title>\n            <jats:p>ClincalTrials.gov NCT06456983, registered 7 Jun 2024. Deutsches Register Klinischer Studien DRKS00036886, registered 14 May 2025.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/s12888-025-06990-2","type":"journal-article","created":{"date-parts":[[2025,5,26]],"date-time":"2025-05-26T09:35:33Z","timestamp":1748252133000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Study protocol of a German multi-center, observer-blind, randomized, and actively controlled parallel-group trial comparing maintenance electroconvulsive therapy to treatment as usual for relapse prevention in clozapine resistant schizophrenia"],"prefix":"10.1186","volume":"25","author":[{"ORCID":"https:\/\/orcid.org\/0009-0005-3208-1532","authenticated-orcid":false,"given":"Anton","family":"Deicher","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5406-7137","authenticated-orcid":false,"given":"Sebastian","family":"Karl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5695-0716","authenticated-orcid":false,"given":"Marie-Luise","family":"Otte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3170-111X","authenticated-orcid":false,"given":"Johannes","family":"Knabbe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernadette","family":"Wendel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Gose","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5358-5212","authenticated-orcid":false,"given":"R. Christian","family":"Wolf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1243-3693","authenticated-orcid":false,"given":"Alexander","family":"Sartorius","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,5,26]]},"reference":[{"issue":"10","key":"6990_CR1","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1016\/j.euroneuro.2011.08.008","volume":"21","author":"A Gustavsson","year":"2011","unstructured":"Gustavsson A, Svensson M, Jacobi F, Allgulander C, Alonso J, Beghi E. u. A. Cost of disorders of the brain in Europe 2010. Eur Neuropsychopharmacol J Eur Coll Neuropsychopharmacol Oktober. 2011;21(10):718\u201379.","journal-title":"Eur Neuropsychopharmacol J Eur Coll Neuropsychopharmacol Oktober"},{"key":"6990_CR2","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1192\/bjp.178.6.506","volume":"178","author":"G Harrison","year":"2001","unstructured":"Harrison G, Hopper K, Craig T, Laska E, Siegel C, Wanderling J. u. A. Recovery from psychotic illness: A.15- A.d 25-year international follow-up study. Br J Psychiatry J Ment Sci Juni. 2001;178:506\u201317.","journal-title":"Br J Psychiatry J Ment Sci Juni"},{"issue":"1","key":"6990_CR3","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1038\/sj.mp.4001777","volume":"11","author":"TR Insel","year":"2006","unstructured":"Insel TR, Scolnick EM. Cure therapeutics and strategic prevention: Raising the bar for mental health research. Mol Psychiatry Januar. 2006;11(1):11\u20137.","journal-title":"Mol Psychiatry Januar"},{"key":"6990_CR4","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1192\/bjp.bp.105.020982","volume":"191","author":"S Marwaha","year":"2007","unstructured":"Marwaha S, Johnson S, Bebbington P, Stafford M, Angermeyer MC, Brugha T. u. A. Rates A.d correlates of employment in people with schizophrenia in the UK, France A.d Germany. Br J Psychiatry J Ment Sci Juli. 2007;191:30\u20137.","journal-title":"Br J Psychiatry J Ment Sci Juli"},{"issue":"3","key":"6990_CR5","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1176\/appi.ajp.161.3.473","volume":"161","author":"DG Robinson","year":"2004","unstructured":"Robinson DG, Woerner MG, McMeniman M, Mendelowitz A, Bilder RM. Symptomatic and functional recovery from a first episode of schizophrenia or schizoaffective disorder. Am J Psychiatry M\u00e4rz. 2004;161(3):473\u20139.","journal-title":"Am J Psychiatry M\u00e4rz"},{"issue":"7321","key":"6990_CR6","first-page":"187","volume":"468","author":"TR Insel","year":"2010","unstructured":"Insel TR. Rethinking schizophrenia. Nat 11 November. 2010;468(7321):187\u201393.","journal-title":"Nat 11 November"},{"issue":"4","key":"6990_CR7","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1001\/jamapsychiatry.2014.2502","volume":"72","author":"ER Walker","year":"2015","unstructured":"Walker ER, McGee RE, Druss BG. Mortality in mental disorders and global disease burden implications: a systematic review and meta-analysis. JAMA Psychiatry April. 2015;72(4):334\u201341.","journal-title":"JAMA Psychiatry April"},{"issue":"2","key":"6990_CR8","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1097\/YCO.0b013e3283366427","volume":"23","author":"M Zink","year":"2010","unstructured":"Zink M, Englisch S, Meyer-Lindenberg A. Polypharmacy in schizophrenia. Curr Opin Psychiatry M\u00e4rz. 2010;23(2):103\u201311.","journal-title":"Curr Opin Psychiatry M\u00e4rz"},{"issue":"3","key":"6990_CR9","first-page":"CD006324","volume":"3","author":"S Barber","year":"2017","unstructured":"Barber S, Olotu U, Corsi M, Cipriani A. Clozapine combined with different antipsychotic drugs for treatment-resistant schizophrenia. Cochrane Database Syst Rev 23 M\u00e4rz. 2017;3(3):CD006324.","journal-title":"Cochrane Database Syst Rev 23 M\u00e4rz"},{"key":"6990_CR10","doi-asserted-by":"crossref","unstructured":"Cipriani A, Boso M, Barbui C. Clozapine combined with different antipsychotic drugs for treatment resistant schizophrenia. Cochrane Database Syst Rev 8 Juli 2009;(3):CD006324.","DOI":"10.1002\/14651858.CD006324.pub2"},{"key":"6990_CR11","unstructured":"DGPPN. S3-Leitlinie Schizophrenie. Langfassung Version 10. 2019."},{"key":"6990_CR12","doi-asserted-by":"crossref","unstructured":"DGPPN. Indikationen Zur EKT. Nervenheilkunde. 2022;(41):706\u20139.","DOI":"10.1055\/a-1917-9004"},{"key":"6990_CR13","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1192\/bjp.151.2.152","volume":"151","author":"KR Abraham","year":"1987","unstructured":"Abraham KR, Kulhara P. The efficacy of electroconvulsive therapy in the treatment of schizophrenia. A comparative study. Br J Psychiatry J Ment Sci August. 1987;151:152\u20135.","journal-title":"Br J Psychiatry J Ment Sci August"},{"issue":"4","key":"6990_CR14","doi-asserted-by":"publisher","first-page":"e61","DOI":"10.1097\/YCT.0b013e31821a8f05","volume":"27","author":"F Biedermann","year":"2011","unstructured":"Biedermann F, Pfaffenberger N, Baumgartner S, Kemmler G, Fleischhacker WW, Hofer A. Combined clozapine and electroconvulsive therapy in clozapine-resistant schizophrenia: clinical and cognitive outcomes. J ECT Dezember. 2011;27(4):e61\u201362.","journal-title":"J ECT Dezember"},{"issue":"6","key":"6990_CR15","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1007\/s00406-010-0173-3","volume":"261","author":"D Kristensen","year":"2011","unstructured":"Kristensen D, Bauer J, Hageman I, J\u00f8rgensen MB. Electroconvulsive therapy for treating schizophrenia: a chart review of patients from two catchment areas. Eur Arch Psychiatry Clin Neurosci September. 2011;261(6):425\u201332.","journal-title":"Eur Arch Psychiatry Clin Neurosci September"},{"issue":"3","key":"6990_CR16","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/S0278-5846(02)00354-8","volume":"27","author":"WK Tang","year":"2003","unstructured":"Tang WK, Ungvari GS. Efficacy of electroconvulsive therapy in treatment-resistant schizophrenia: a prospective open trial. Prog Neuropsychopharmacol Biol Psychiatry Mai. 2003;27(3):373\u20139.","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry Mai"},{"issue":"8183","key":"6990_CR17","doi-asserted-by":"publisher","first-page":"1380","DOI":"10.1016\/S0140-6736(80)92653-7","volume":"1","author":"P Taylor","year":"1980","unstructured":"Taylor P, Fleminger JJ. ECT for schizophrenia. Lancet Lond Engl 28 Juni. 1980;1(8183):1380\u20132.","journal-title":"Lancet Lond Engl 28 Juni"},{"key":"6990_CR18","doi-asserted-by":"crossref","unstructured":"Tharyan P, Adams CE. Electroconvulsive therapy for schizophrenia. Cochrane Database Syst Rev 18 April 2005;(2):CD000076.","DOI":"10.1002\/14651858.CD000076.pub2"},{"key":"6990_CR19","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1016\/j.psychres.2017.01.042","volume":"249","author":"S Grover","year":"2017","unstructured":"Grover S, Chakrabarti S, Hazari N, Avasthi A. Effectiveness of electroconvulsive therapy in patients with treatment resistant schizophrenia: A retrospective study. Psychiatry Res M\u00e4rz. 2017;249:349\u201353.","journal-title":"Psychiatry Res M\u00e4rz"},{"issue":"1","key":"6990_CR20","doi-asserted-by":"publisher","first-page":"58","DOI":"10.4306\/pi.2017.14.1.58","volume":"14","author":"HS Kim","year":"2017","unstructured":"Kim HS, Kim SH, Lee NY, Youn T, Lee JH, Chung S. u. A. Effectiveness of electroconvulsive therapy augmentation on Clozapine-Resistant schizophrenia. Psychiatry Investig Januar. 2017;14(1):58\u201362.","journal-title":"Psychiatry Investig Januar"},{"issue":"23","key":"6990_CR21","doi-asserted-by":"publisher","first-page":"4287","DOI":"10.3923\/pjbs.2007.4287.4290","volume":"10","author":"A Masoudzadeh","year":"2007","unstructured":"Masoudzadeh A, Khalilian AR. Comparative study of clozapine, electroshock and the combination of ECT with clozapine in treatment-resistant schizophrenic patients. Pak J Biol Sci PJBS 1 Dezember. 2007;10(23):4287\u201390.","journal-title":"Pak J Biol Sci PJBS 1 Dezember"},{"issue":"1","key":"6990_CR22","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1176\/appi.ajp.2014.13060787","volume":"172","author":"G Petrides","year":"2015","unstructured":"Petrides G, Malur C, Braga RJ, Bailine SH, Schooler NR, Malhotra AK. u. A. Electroconvulsive therapy A.gmentation in clozapine-resistant schizophrenia: A.prospective, randomized study. Am J Psychiatry Januar. 2015;172(1):52\u20138.","journal-title":"Am J Psychiatry Januar"},{"issue":"3","key":"6990_CR23","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1097\/YCO.0000000000000418","volume":"31","author":"SN Sanghani","year":"2018","unstructured":"Sanghani SN, Petrides G, Kellner CH. Electroconvulsive therapy (ECT) in schizophrenia: a review of recent literature. Curr Opin Psychiatry Mai. 2018;31(3):213\u201322.","journal-title":"Curr Opin Psychiatry Mai"},{"key":"6990_CR24","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.psychres.2018.03.033","volume":"264","author":"HB Ward","year":"2018","unstructured":"Ward HB, Szabo ST, Rakesh G. Maintenance ECT in schizophrenia: A systematic review. Psychiatry Res Juni. 2018;264:131\u201342.","journal-title":"Psychiatry Res Juni"},{"issue":"3","key":"6990_CR25","first-page":"156","volume":"35","author":"RJ Braga","year":"2019","unstructured":"Braga RJ, John M, Schooler NR, Bailine SH, Malur C, Mendelowitz A. u. A. Continuation electroconvulsive therapy for patients with Clozapine-Resistant schizophrenia: A pilot study. J ECT September. 2019;35(3):156\u201360.","journal-title":"J ECT September"},{"issue":"3","key":"6990_CR26","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1016\/j.psychres.2008.10.012","volume":"175","author":"M L\u00e9vy-Rueff","year":"2010","unstructured":"L\u00e9vy-Rueff M, Gourevitch R, L\u00f4o H, Oli\u00e9 JP, Amado I. Maintenance electroconvulsive therapy: an alternative treatment for refractory schizophrenia and schizoaffective disorders. Psychiatry Res 28 Februar. 2010;175(3):280\u20133.","journal-title":"Psychiatry Res 28 Februar"},{"issue":"3","key":"6990_CR27","doi-asserted-by":"publisher","first-page":"799","DOI":"10.2466\/pr0.1962.10.3.799","volume":"10","author":"JE Overall","year":"1962","unstructured":"Overall JE, Gorham DR. The brief psychiatric rating scale. Psychol Rep 1 Juni. 1962;10(3):799\u2013812.","journal-title":"Psychol Rep 1 Juni"},{"key":"6990_CR28","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/1744-859X-10-2","volume":"10","author":"IHM Aas","year":"2011","unstructured":"Aas IHM. Guidelines for rating global assessment of functioning (GAF). Ann Gen Psychiatry 20 Januar. 2011;10:2.","journal-title":"Ann Gen Psychiatry 20 Januar"},{"issue":"2","key":"6990_CR29","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1093\/schbul\/13.2.261","volume":"13","author":"SR Kay","year":"1987","unstructured":"Kay SR, Fiszbein A, Opler LA. The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophr Bull. 1987;13(2):261\u201376.","journal-title":"Schizophr Bull"},{"issue":"1","key":"6990_CR30","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1136\/jnnp.23.1.56","volume":"23","author":"M Hamilton","year":"1960","unstructured":"Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry Februar. 1960;23(1):56\u201362.","journal-title":"J Neurol Neurosurg Psychiatry Februar"},{"issue":"7","key":"6990_CR31","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1007\/s00115-016-0136-7","volume":"88","author":"D Hirjak","year":"2017","unstructured":"Hirjak D, Thomann PA, Northoff G, Kubera KM, Wolf RC. [German version of the Northoff catatonia rating scale (NCRS-dv): A validated instrument for measuring catatonic symptoms]. Nervenarzt Juli. 2017;88(7):787\u201396.","journal-title":"Nervenarzt Juli"},{"issue":"7","key":"6990_CR32","first-page":"1693","volume":"14","author":"M Ritsner","year":"2005","unstructured":"Ritsner M, Kurs R, Gibel A, Ratner Y, Endicott J. Validity of an abbreviated quality of life enjoyment and satisfaction questionnaire (Q-LES-Q-18) for schizophrenia, schizoaffective, and mood disorder patients. Qual Life Res Int J Qual Life Asp Treat Care Rehabil September. 2005;14(7):1693\u2013703.","journal-title":"Qual Life Res Int J Qual Life Asp Treat Care Rehabil September"},{"issue":"1","key":"6990_CR33","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.psychres.2012.04.009","volume":"199","author":"PW Corrigan","year":"2012","unstructured":"Corrigan PW, Michaels PJ, Vega E, Gause M, Watson AC, R\u00fcsch N. Self-stigma of mental illness scale\u2013short form: reliability and validity. Psychiatry Res 30 August. 2012;199(1):65\u20139.","journal-title":"Psychiatry Res 30 August"},{"issue":"1\u20133","key":"6990_CR34","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.schres.2009.01.006","volume":"110","author":"N R\u00fcsch","year":"2009","unstructured":"R\u00fcsch N, Corrigan PW, Wassel A, Michaels P, Olschewski M, Wilkniss S. u. A. A stress-coping model of mental illness stigma: I. Predictors of cognitive stress A.praisal. Schizophr Res Mai. 2009;110(1\u20133):59\u201364.","journal-title":"Schizophr Res Mai"},{"issue":"3","key":"6990_CR35","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/0022-3956(75)90026-6","volume":"12","author":"MF Folstein","year":"1975","unstructured":"Folstein MF, Folstein SE, McHugh PR. \u201eMini-mental State. A practical method for grading the cognitive State.of patients for the clinician. J Psychiatr Res November. 1975;12(3):189\u201398.","journal-title":"J Psychiatr Res November"},{"issue":"4","key":"6990_CR36","doi-asserted-by":"publisher","first-page":"e1922","DOI":"10.1002\/mpr.1922","volume":"31","author":"M Dalby","year":"2022","unstructured":"Dalby M, Annas P, 23andMe Research Team, Harrison JE. Further validation of the THINC-it tool and extension of the normative data set in a study of n\u2009=\u200910.019 typical controls. Int J Methods Psychiatr Res Dezember. 2022;31(4):e1922.","journal-title":"Int J Methods Psychiatr Res Dezember"},{"key":"6990_CR37","doi-asserted-by":"publisher","first-page":"546","DOI":"10.3389\/fpsyt.2020.00546","volume":"11","author":"RS McIntyre","year":"2020","unstructured":"McIntyre RS, Subramaniapillai M, Park C, Zuckerman H, Cao B, Lee Y. u. A. The THINC-it tool for cognitive assessment A.d measurement in major depressive disorder: sensitivity to change. Front Psychiatry. 2020;11:546.","journal-title":"Front Psychiatry"},{"issue":"3","key":"6990_CR38","doi-asserted-by":"publisher","first-page":"389","DOI":"10.3390\/brainsci13030389","volume":"13","author":"JK Szmyd","year":"2023","unstructured":"Szmyd JK, Lewczuk K, Teopiz KM, McIntyre RS, Wichniak A. THINC-Integrated tool (THINC-it): A brief measurement of changes in cognitive functioning and its correlation with the life quality of patients with schizophrenia and related Disorders-A pilot study. Brain Sci 24 Februar. 2023;13(3):389.","journal-title":"Brain Sci 24 Februar"},{"key":"6990_CR39","doi-asserted-by":"publisher","first-page":"103208","DOI":"10.1016\/j.jbi.2019.103208","volume":"95","author":"PA Harris","year":"2019","unstructured":"Harris PA, Taylor R, Minor BL, Elliott V, Fernandez M, O\u2019Neal L. u. A. The REDCap consortium: Building A. international community of software platform partners. J Biomed Inf Juli. 2019;95:103208.","journal-title":"J Biomed Inf Juli"},{"issue":"2","key":"6990_CR40","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/j.jbi.2008.08.010","volume":"42","author":"PA Harris","year":"2009","unstructured":"Harris PA, Taylor R, Thielke R, Payne J, Gonzalez N, Conde JG. Research electronic data capture (REDCap)--a metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inf April. 2009;42(2):377\u201381.","journal-title":"J Biomed Inf April"},{"issue":"3","key":"6990_CR41","first-page":"178","volume":"15","author":"W Chanpattana","year":"1999","unstructured":"Chanpattana W, Chakrabhand ML, Sackeim HA, Kitaroonchai W, Kongsakon R, Techakasem P. u. A. Continuation ECT in treatment-resistant schizophrenia: A.controlled study. J ECT September. 1999;15(3):178\u201392.","journal-title":"J ECT September"},{"issue":"7","key":"6990_CR42","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1056\/NEJMra2034954","volume":"386","author":"RT Espinoza","year":"2022","unstructured":"Espinoza RT, Kellner CH, Electroconvulsive Therapy. N Engl J Med 17 Februar. 2022;386(7):667\u201372.","journal-title":"N Engl J Med 17 Februar"},{"issue":"6","key":"6990_CR43","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1016\/j.biopsych.2010.06.009","volume":"68","author":"M Semkovska","year":"2010","unstructured":"Semkovska M, McLoughlin DM. Objective cognitive performance associated with electroconvulsive therapy for depression: a systematic review and meta-analysis. Biol Psychiatry 15 September. 2010;68(6):568\u201377.","journal-title":"Biol Psychiatry 15 September"},{"key":"6990_CR44","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/j.jad.2022.08.005","volume":"316","author":"M Yoldi-Negrete","year":"2022","unstructured":"Yoldi-Negrete M, Gill LN, Olivares S, Lauzi\u00e8re A, D\u00e9silets M, Tourjman SV. The effect of continuation and maintenance electroconvulsive therapy on cognition: A systematic review of the literature and meta-analysis. J Affect Disord 1 November. 2022;316:148\u201360.","journal-title":"J Affect Disord 1 November"}],"container-title":["BMC Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12888-025-06990-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12888-025-06990-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12888-025-06990-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,26]],"date-time":"2025-05-26T09:35:37Z","timestamp":1748252137000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpsychiatry.biomedcentral.com\/articles\/10.1186\/s12888-025-06990-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,26]]},"references-count":44,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["6990"],"URL":"https:\/\/doi.org\/10.1186\/s12888-025-06990-2","relation":{},"ISSN":["1471-244X"],"issn-type":[{"value":"1471-244X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,26]]},"assertion":[{"value":"12 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The trial was approved by the Ethics Committee II of the Medical Faculty Mannheim. All patients will provide written informed consent to participate in the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"536"}}